224 related articles for article (PubMed ID: 15972863)
1. Tailoring arthritis therapy in the wake of the NSAID crisis.
Olsen NJ
N Engl J Med; 2005 Jun; 352(25):2578-80. PubMed ID: 15972863
[No Abstract] [Full Text] [Related]
2. Raising the safety bar--the FDA's coxib meeting.
Okie S
N Engl J Med; 2005 Mar; 352(13):1283-5. PubMed ID: 15800221
[No Abstract] [Full Text] [Related]
3. COX-2 inhibitors--a lesson in unexpected problems.
Drazen JM
N Engl J Med; 2005 Mar; 352(11):1131-2. PubMed ID: 15713947
[No Abstract] [Full Text] [Related]
4. The COX-2 inhibitors--an update.
Furberg CD
Am Heart J; 2006 Aug; 152(2):197-9. PubMed ID: 16875896
[No Abstract] [Full Text] [Related]
5. The safety of the perioperative administration of cyclooxygenase-2 inhibitors for post-surgical pain.
Reuben SS
Acta Anaesthesiol Scand; 2005 Mar; 49(3):424; author reply 425. PubMed ID: 15752415
[No Abstract] [Full Text] [Related]
6. [Gastrointestinal complications caused by NSAIDs. Over 60% of arthrosis patients are endangered].
MMW Fortschr Med; 2003 Mar; 145(10):60. PubMed ID: 12688036
[No Abstract] [Full Text] [Related]
7. Drug safety. FDA panel urges caution on many anti-inflammatory drugs.
Couzin J
Science; 2005 Feb; 307(5713):1183-5. PubMed ID: 15731414
[No Abstract] [Full Text] [Related]
8. The coxibs, selective inhibitors of cyclooxygenase-2.
FitzGerald GA; Patrono C
N Engl J Med; 2001 Aug; 345(6):433-42. PubMed ID: 11496855
[No Abstract] [Full Text] [Related]
9. COX-2 inhibitors and cardiovascular toxicity: a class effect?
Laible B
S D J Med; 2005 Mar; 58(3):93-4. PubMed ID: 15794479
[No Abstract] [Full Text] [Related]
10. [Selective Cox-2 inhibitor in osteoarthritis and rheumatoid arthritis. No increased risk for the heart].
MMW Fortschr Med; 2003 Mar; 145(11):60. PubMed ID: 12688204
[No Abstract] [Full Text] [Related]
11. COX-2 inhibitors still eyed for cancer prevention.
Thompson CA
Am J Health Syst Pharm; 2005 May; 62(9):890, 894. PubMed ID: 15851492
[No Abstract] [Full Text] [Related]
12. Why don't we initiate more large simple randomized controlled trials?
Wright JM
CMAJ; 2003 Nov; 169(11):1170-1. PubMed ID: 14638653
[No Abstract] [Full Text] [Related]
13. Selective COX-2 inhibition.
Silas S; Clegg DO
Bull Rheum Dis; 1999; 48(2):1-4. PubMed ID: 12024416
[No Abstract] [Full Text] [Related]
14. The pain game.
Wadman M
Nature; 2007 Jul; 448(7152):400-1. PubMed ID: 17653159
[No Abstract] [Full Text] [Related]
15. Non-steroidal anti-inflammatory drugs in orofacial pain management--an update.
van der Bijl P; van der Bijl P
SADJ; 2002 Aug; 57(8):328-31. PubMed ID: 12428528
[No Abstract] [Full Text] [Related]
16. [Financial interests characterize published reports on coxiber. Whom can we rely on?].
Håkansson J
Lakartidningen; 2002 Oct; 99(40):3930-1. PubMed ID: 12422746
[No Abstract] [Full Text] [Related]
17. [New treatment of pain and fever in rheumatoid arthritis and arthrosis. The first cyclooxygenase-2 inhibitors show promising results].
Oliw E; Wollheim FA
Lakartidningen; 2000 Jun; 97(24):2942-4. PubMed ID: 10900877
[No Abstract] [Full Text] [Related]
18. [Side effects cause enormous costs. Expensive arthritis therapy].
MMW Fortschr Med; 2001 Nov; 143(46):60. PubMed ID: 11759607
[No Abstract] [Full Text] [Related]
19. Vioxx doctors wooed by Merck are now its foes.
Tesoriero HW
Wall St J (East Ed); 2006 Mar; ():B1, B3. PubMed ID: 16578911
[No Abstract] [Full Text] [Related]
20. [New anti-inflammatory analgetics--are they needed?].
Paakkari I
Duodecim; 1999; 115(20):2217-24. PubMed ID: 11973925
[No Abstract] [Full Text] [Related]
[Next] [New Search]
